Biofrontera (BFRI) Non Operating Income (2020 - 2026)
Biofrontera (BFRI) posted quarterly Non Operating Income of -$208000.0 for Q4 2025, down 166.45% year-over-year from $313000.0 in Q4 2024, and down 87.39% quarter-over-quarter from -$111000.0 in Q3 2025.
Biofrontera (BFRI) Non Operating Income (2020 - 2026) Analysis & Trends
Biofrontera's Non Operating Income history runs 6 years deep, the most recent figure standing at -$208000.0 for Q4 2025.
- In Q4 2025, Non Operating Income fell 166.45% year-over-year to -$208000.0; the TTM figure through Dec 2025 stood at -$540000.0 (down 117.8% YoY), while the FY2025 annual figure was -$452000.0, up 14.23% from the prior year.
- Non Operating Income for Q4 2025 stood at -$208000.0, down from -$111000.0 in the prior quarter.
- The five-year high for Non Operating Income was $8.7 million in Q1 2022, with the low at -$12.6 million in Q4 2021.
- The 5-year median for Non Operating Income is -$108500.0 (2025), against an average of $227600.0.
- The sharpest annual moves came in 2022 and 2024: Non Operating Income soared 174120.0% in 2022, then slumped 397.18% in 2024.
- Biofrontera's Non Operating Income stood at -$12.6 million in 2021, then jumped by 122.47% to $2.8 million in 2022, then plunged by 107.48% to -$212000.0 in 2023, then soared by 247.64% to $313000.0 in 2024, then slumped by 166.45% to -$208000.0 in 2025.
- Business Quant data shows BFRI's Non Operating Income at -$208000.0 in Q4 2025, -$111000.0 in Q3 2025, and -$115000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | -57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -126,000.00 |
| Dec 31, 2025 | -208,000.00 |
| Sep 30, 2025 | -111,000.00 |
| Jun 30, 2025 | -115,000.00 |
| Mar 31, 2025 | -106,000.00 |
| Dec 31, 2024 | 313,000.00 |
| Sep 30, 2024 | -706,000.00 |
| Jun 30, 2024 | 4.83 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -212,000.00 |
| Sep 30, 2023 | -142,000.00 |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -1.98 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 5.36 Mn |
| Mar 31, 2022 | 8.70 Mn |
| Dec 31, 2021 | -12.62 Mn |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 70,000.00 |